Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary treatment for Borderline personality disorder (BPD) is specialized psychotherapy, specifically modalities designed to improve emotional regulation and interpersonal functioning. While no medication is FDA-approved specifically to treat BPD, clinicians often prescribe drugs to manage co-occurring symptoms like anxiety, depression, or mood instability as part of a comprehensive care plan. What are the first-line psychotherapeutic treatments for BPD? Evidence-based psychotherapy is the cornerstone of managing Borderline personality disorder (BPD).
3 people with Borderline personality disorder (BPD) have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Borderline personality disorder (BPD) is specialized psychotherapy, specifically modalities designed to improve emotional regulation and interpersonal functioning. While no medication is FDA-approved specifically to treat BPD, clinicians often prescribe drugs to manage co-occurring symptoms like anxiety, depression, or mood instability as part of a comprehensive care plan.
Evidence-based psychotherapy is the cornerstone of managing Borderline personality disorder (BPD). These treatments focus on reducing self-harm behaviors and improving quality of life through skill-building:
There is no "cure-all" pill for Borderline personality disorder (BPD). However, physicians may prescribe medications off-label to address specific symptoms. Common classes include mood stabilizers (such as lamotrigine), second-generation antipsychotics (such as quetiapine or aripiprazole), and antidepressants (SSRIs) if the patient also experiences significant depression or anxiety. Treatment must be personalized, as effectiveness varies greatly between individuals.
A multidisciplinary approach is essential for long-term stability in Borderline personality disorder (BPD). A typical care team includes:
Research into Borderline personality disorder (BPD) is evolving, with ongoing clinical trials exploring the use of neurofeedback, transcranial magnetic stimulation (TMS), and short-term intensive residential programs. These interventions aim to provide faster relief for acute crises, though they remain supplemental to long-term psychotherapy.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with your healthcare provider for personalized medical decisions.